CCR8 and Autoimmunity: While near complete loss of the Treg cell pool in KP-DTR mice led to systemic autoimmunity and inflammation, VEGF blockade coupled with CCR8 antibody-mediated depletion of intratumoral Treg cells showed impressive therapeutic efficacy with no adverse effects.